The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
The Risk of Seizures after Receipt of Whole-Cell Pertussis or Measles, Mumps, and Rubella Vaccine
Open accessAbstract
BACKGROUND: The administration of the diphtheria and tetanus toxoids and whole-cell pertussis (DTP) vaccine and measles, mumps, and rubella (MMR) vaccine has been associated with adverse neurologic events, including seizures. We studied the relation between these vaccinations and the risk of a first seizure, subsequent seizures, and neurodevelopmental disability in children. METHODS: This cohort study was conducted at four large health maintenance organizations and included reviews of the medical records of children with seizures. We calculated the relative risks of febrile and nonfebrile seizures among 679,942 children after 340,386 vaccinations with DTP vaccine, 137,457 vaccinations with MMR vaccine, or no recent vaccination. Children who had febrile seizures after vaccination were followed to identify the risk of subsequent seizures and other neurologic disabilities. RESULTS: Receipt of DTP vaccine was associated with an increased risk of febrile seizures only on the day of vaccination (adjusted relative risk, 5.70; 95 percent confidence interval, 1.98 to 16.42). Receipt of MMR vaccine was associated with an increased risk of febrile seizures 8 to 14 days after vaccination (relative risk, 2.83; 95 percent confidence interval, 1.44 to 5.55). Neither vaccination was associated with an increased risk of nonfebrile seizures. Analyses of automated data alone gave results similar to the analyses of the data from medical-record reviews. The number of febrile seizures attributable to the administration of DTP and MMR vaccines was estimated to be 6 to 9 and 25 to 34 per 100,000 children, respectively. As compared with other children with febrile seizures that were not associated with vaccination, the children who had febrile seizures after vaccination were not found to be at higher risk for subsequent seizures or neurodevelopmental disabilities. CONCLUSIONS: There are significantly elevated risks of febrile seizures on the day of receipt of DTP vaccine and 8 to 14 days after the receipt of MMR vaccine, but these risks do not appear to be associated with any long-term, adverse consequences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robust Variance Estimation for the Case-Cohort Design
Barlow, W. E. (1994) · Biometrics · doi:10.2307/2533444 · Cited by 540
Self-citationThe Vaccine Adverse Event Reporting System (VAERS)
CHEN, R., RASTOGI, S., MULLEN, J., HAYES, S., COCHI, S., DONLON, J., & WASSILAK, S. (1994) · Vaccine · doi:10.1016/0264-410x(94)90315-8 · Cited by 498
Self-citationThe Vaccine Adverse Event Reporting System (VAERS)
(1994) · Vaccine · doi:10.1016/0264-410x(94)90044-2 · Cited by 392
Chen, R. T., Glasser, J. W., Rhodes, P. H., Davis, R. L., Barlow, W. E., Thompson, R. S., Mullooly, J. P., Black, S. B., Shinefield, H. R., Vadheim, C. M., et al. (1997) · PEDIATRICS · doi:10.1542/peds.99.6.765 · Cited by 346
Self-citationFarrington, P., Rush, M., Miller, E., Pugh, S., Colville, A., Flower, A., Nash, J., & Morgan-Capner, P. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90471-9 · Cited by 338
Long-Term Intellectual and Behavioral Outcomes of Children with Febrile Convulsions
Verity, C. M., Greenwood, R., & Golding, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806113382403 · Cited by 246
VACCINATION AGAINST WHOOPING COUGH
MADSEN, T. (1933) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1933.02740280007003 · Cited by 243
Fitting Cox's proportional hazards models from survey data
BINDER, D. A. (1992) · Biometrika · doi:10.1093/biomet/79.1.139 · Cited by 228
Febrile Seizures and Later Intellectual Performance
Ellenberg, J. H., & Nelson, K. B. (1978) · Archives of Neurology · doi:10.1001/archneur.1978.00500250021004 · Cited by 227
Pertussis in Sweden after the cessation of general immunization in 1979
ROMANUS, V., JONSELL, R., & BERGQUIST, S.-O. (1987) · Pediatric Infectious Disease Journal · doi:10.1097/00006454-198704000-00005 · Cited by 192
Epidemiology of encephalitis in children. A prospective multicentre study
Koskiniemi, M., Korppi, M. O., Mustonen, K., Rantala, H., Muttilainen, M., Herrgård, E. A., Ukkonen, P., & Vaheri, A. (1997) · European Journal of Pediatrics · doi:10.1007/s004310050658 · Cited by 144
Risk of Seizures and Encephalopathy After Immunization With the Diphtheria-Tetanus-Pertussis Vaccine
Griffin, M. R., Ray, W. A., Mortimer, E. A., Fenichel, G. M., & Schaffner, W. (1990) · JAMA · doi:10.1001/jama.1990.03440120063038 · Cited by 138
Adverse Effects of Pertussis and Rubella Vaccines
Institute of Medicine (1991) · National Academies Press eBooks · doi:10.17226/1815 · Cited by 121
Gale, J. L. (1994) · JAMA · doi:10.1001/jama.271.1.37 · Cited by 106
Neurologic Events Following Diphtheria-Tetanus-Pertussis Immunization
Walker, A. M., Jick, H., Perera, D. R., Knauss, T. A., & Thompson, R. S. (1988) · PEDIATRICS · doi:10.1542/peds.81.3.345 · Cited by 96
Self-citationRisk of Seizures After Measles-Mumps-Rubella Immunization
Griffin, M. R., Ray, W. A., Mortimer, E. A., Fenichel, G. M., & Schaffner, W. (1991) · PEDIATRICS · doi:10.1542/peds.88.5.881 · Cited by 87
Quality of HMO Vaccination Databases Used to Monitor Childhood Vaccine Safety
Mullooly, J. P., Drew, L., Destefano, F. R., Chen, R. Q., Okoro, K., Swint, E. B., Immanuel, V., Ray, P., Lewis, N., Vadheim, C. M., et al. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009785 · Cited by 70
Self-citationEkwueme, D. U., Strebel, P. M., Hadler, S. C., Meltzer, M. I., Allen, J. W., & Livengood, J. R. (2000) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.154.8.797 · Cited by 66
Measles Virus Infections of the Central Nervous System
Liebert, U. G. (1997) · Intervirology · doi:10.1159/000150544 · Cited by 55
Thompson, R. S. (1996) · Milbank Quarterly · doi:10.2307/3350390 · Cited by 51
Self-citationPayne, T. H., Kanvik, S., Seward, R., Beeman, D., Salazar, A., Miller, Z., Immanuel, V., & Thompson, R. S. (1993) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(18)30747-5 · Cited by 35
Self-citationMiller, D. L., Wadsworth, J., & Ross, E. M. (1988) · PubMed · Cited by 32
Surveillance of vaccine-related adverse events in the first year of life: A Manitoba Cohort study
Roberts, J. D., Roos, L. L., Poffenroth, L., et al. (1996) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00522-6 · Cited by 30
Immunization tracking systems: experience of the CDC Vaccine Safety Datalink sites.
Davis, R. L., BLACK, S. B., Vadheim, C. M., Shinefield, H., Baker, B., Pearson, D., & Chen, R. (1997) · PubMed · Cited by 12
Self-citation
Cited by
Guerrini, R. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68182-8 · Cited by 848
Waruiru, C. (2004) · Archives of Disease in Childhood · doi:10.1136/adc.2003.028449 · Cited by 422
Vaccines for measles, mumps and rubella in children
Demicheli, V., Rivetti, A., Debalini, M. G., & Di Pietrantonj, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004407.pub3 · Cited by 372
Measles-Mumps-Rubella-Varicella Combination Vaccine and the Risk of Febrile Seizures
Klein, N. P., Fireman, B., Yih, W. K., Lewis, E., Kulldorff, M., Ray, P., Baxter, R., Hambidge, S., Nordin, J., Naleway, A., et al. (2010) · Pediatrics · doi:10.1542/peds.2010-0665 · Cited by 316
Berkovic, S. F., Harkin, L., McMahon, J. M., Pelekanos, J. T., Zuberi, S. M., Wirrell, E. C., Gill, D. S., Iona, X., Mulley, J. C., & Scheffer, I. E. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70446-x · Cited by 294
Metadata
- Authors
- Barlow, W. E., Davis, R. L., Glasser, J. W., Rhodes, P. H., Thompson, R. S., Mullooly, J. P., Black, S. B., Shinefield, H. R., Ward, J. I., Marcy, S. M., DeStefano, F., Immanuel, V., Pearson, J. A., Vadheim, C. M., Rebolledo, V., Christakis, D., Benson, P. J., Lewis, N., & Chen, R. T.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2001-08-30
- Volume
- 345
- Issue
- 9
- Pages
- 656-661
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1973088910
- Cited by
- 325
- References
- 24
- FWCI
- 13.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.